ArticleFrontiers in oncology2022

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.

Hervé Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.